ORUM (KQ:475830) — Market Cap & Net Worth
Market Cap & Net Worth: ORUM (475830)
ORUM (KQ:475830) has a market capitalization of $293.91K (₩433.69 Million) as of August 4, 2026. Listed on the KQ stock exchange, this Korea-based company holds position #31083 globally and #2110 in its home market, demonstrating a -6.50% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying ORUM's stock price ₩44600.00 by its total outstanding shares 9724 (9.72K). See reinvestment intensity of ORUM to understand how much of operating cash flow is reinvested back into capital assets.
ORUM Market Cap History: 2025 to 2026
ORUM's market capitalization history from 2025 to 2026. Data shows growth from $790.78K to $293.91K (0.00% CAGR).
ORUM Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how ORUM's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
No P/S ratio data available
Latest Price to Earnings (P/E) Ratio
No P/E ratio data available
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| No financial ratio data available | |||||
Competitor Companies of 475830 by Market Capitalization
Companies near ORUM in the global market cap rankings as of August 4, 2026.
Key companies related to ORUM by market ranking:
- Vertex Pharmaceuticals Inc (NASDAQ:VRTX): Ranked #220 globally with a market cap of $110.45 Billion USD.
- Regeneron Pharmaceuticals Inc (NASDAQ:REGN): Ranked #424 globally with a market cap of $64.60 Billion USD.
- Argen-X (BR:ARGX): Ranked #543 globally with a market cap of $49.55 Billion USD ( €42.38 Billion EUR).
- UCB SA (BR:UCB): Ranked #563 globally with a market cap of $47.34 Billion USD ( €40.49 Billion EUR).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #220 | Vertex Pharmaceuticals Inc | NASDAQ:VRTX | $110.45 Billion | $477.10 |
| #424 | Regeneron Pharmaceuticals Inc | NASDAQ:REGN | $64.60 Billion | $762.63 |
| #543 | Argen-X | BR:ARGX | $49.55 Billion | €745.00 |
| #563 | UCB SA | BR:UCB | $47.34 Billion | €222.90 |
ORUM Historical Marketcap From 2025 to 2026
Between 2025 and today, ORUM's market cap moved from $790.78K to $ 293.91K, with a yearly change of 0.00%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | ₩293.91K | -62.83% |
| 2025 | ₩790.78K | -- |
End of Day Market Cap According to Different Sources
On Aug 3rd, 2026 the market cap of ORUM was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $293.91K USD |
| MoneyControl | $293.91K USD |
| MarketWatch | $293.91K USD |
| marketcap.company | $293.91K USD |
| Reuters | $293.91K USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About ORUM
Orum Therapeutics, Inc., a biopharmaceutical company, engages in the research and development of pharmaceuticals for cancer and immune diseases. The company develops BMS-986497 (ORM-6151), which is in phase 1 clinical trial to treat acuta myeloid leukemia and high-risk myelodysplastic syndromes; ORM-1153, which is in preclinical trial to treat acuta myeloid leukemia and heme-onc; and ORM-1023, wh… Read more